Latham Represents Caris Life Sciences in Raising US$168 Million in Private Capital From Leading Investors

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, has announced that the company has closed a growth capital funding round of US$168 million. With this funding, Caris has raised US$1.86 billion in capital since 2018. Braidwell LP, a leading life science-focused investment firm and an existing investor, led the financing with participation from new investors Perceptive Advisors, Woodline, and Ghisallo, along with additional new investors. Several existing investors are also participating in the round including Millennium Management and First Light Asset Management.

Latham & Watkins LLP represented Caris in the transaction with a corporate team led by partners Nathan Ajiashvili and Samer Zabaneh, with associates Omar Ammash, Sandy Kugbei, Cooper Shear, and Samantha Cioppa.